Michael J. Labarre - Net Worth and Insider Trading
Michael J. Labarre Net Worth
The estimated net worth of Michael J. Labarre is at least $8 Million dollars as of 2024-12-27. Michael J. Labarre is the SVP, CHIEF TECHNICAL OFFICER of Halozyme Therapeutics Inc and owns about 173,756 shares of Halozyme Therapeutics Inc (HALO) stock worth over $8 Million. Details can be seen in Michael J. Labarre's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael J. Labarre has not made any transactions after 2024-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael J. Labarre
Michael J. Labarre Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael J. Labarre owns 1 companies in total, including Halozyme Therapeutics Inc (HALO) .
Click here to see the complete history of Michael J. Labarre’s form 4 insider trades.
Insider Ownership Summary of Michael J. Labarre
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2024-10-16 | SVP & Chief Technical Officer |
Michael J. Labarre Latest Holdings Summary
Michael J. Labarre currently owns a total of 1 stock. Michael J. Labarre owns 173,756 shares of Halozyme Therapeutics Inc (HALO) as of October 16, 2024, with a value of $8 Million.
Latest Holdings of Michael J. Labarre
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2024-10-16 | 173,756 | 47.96 | 8,333,338 |
Holding Weightings of Michael J. Labarre
Michael J. Labarre Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael J. Labarre has made a total of 35 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 35 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 20,000 shares on October 16, 2024, which brought Michael J. Labarre around $1 Million.
Insider Trading History of Michael J. Labarre
- 1
Michael J. Labarre Trading Performance
Michael J. Labarre Ownership Network
Michael J. Labarre Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Michael J. Labarre is the SVP & Chief Technical Officer of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include director & President and CEO Helen Torley , SVP & Chief Financial Officer Nicole Labrosse , and SVP & General Counsel Mark Howard Snyder .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Michael J. Labarre made 16 insider transaction in Halozyme Therapeutics Inc (HALO) with a net sale of 270,000. Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 200,000 shares made by Helen Torley , a net sale of 49,881 shares made by Matthew L. Posard , and a net sale of 35,000 shares made by Nicole Labrosse .
In summary, during the past 3 months, insiders sold 40,000 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 40,000 shares. During the past 18 months, 574,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 574,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Michael J. Labarre Mailing Address
Above is the net worth, insider trading, and ownership report for Michael J. Labarre. You might contact Michael J. Labarre via mailing address: 11388 Sorrento Valley Road, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
